Journal article
Ethical Considerations in the Design and Conduct of Clinical Trials of Artificial Intelligence
JAMA network open, Vol.7(9), e2432482
09/03/2024
DOI: 10.1001/jamanetworkopen.2024.32482
PMCID: PMC11380101
PMID: 39240560
Abstract
This qualitative study of investigators involved in clinical trials using artificial intelligence (AI) in diabetic retinopathy screening analyzes semi-structured interviews on the generalizability of National Institute of Health ethical research principles that may be unique to AI.
Details
- Title: Subtitle
- Ethical Considerations in the Design and Conduct of Clinical Trials of Artificial Intelligence
- Creators
- Alaa Youssef - Stanford UniversityAriadne A. Nichol - Stanford UniversityNicole Martinez-Martin - Stanford University School of MedicineDavid B. Larson - Stanford UniversityMichael Abramoff - University of IowaRisa M. Wolf - Johns Hopkins University School of MedicineDanton Char - Stanford University
- Resource Type
- Journal article
- Publication Details
- JAMA network open, Vol.7(9), e2432482
- DOI
- 10.1001/jamanetworkopen.2024.32482
- PMID
- 39240560
- PMCID
- PMC11380101
- NLM abbreviation
- JAMA Netw Open
- ISSN
- 2574-3805
- eISSN
- 2574-3805
- Publisher
- American Medical Association
- Grant note
- National Eye Institute: R01EY033233-01
This study was funded by the National Eye Institute (R01EY033233-01).
- Alternative title
- Ethical Considerations in the Design and Conduct of Clinical Trials of AI
- Language
- English
- Date published
- 09/03/2024
- Academic Unit
- Electrical and Computer Engineering; Fraternal Order of Eagles Diabetes Research Center; Ophthalmology and Visual Sciences
- Record Identifier
- 9984701823102771
Metrics
63 Record Views